FI953851A0 - Silylerade acetylkolinesterasinhibitorer - Google Patents
Silylerade acetylkolinesterasinhibitorerInfo
- Publication number
- FI953851A0 FI953851A0 FI953851A FI953851A FI953851A0 FI 953851 A0 FI953851 A0 FI 953851A0 FI 953851 A FI953851 A FI 953851A FI 953851 A FI953851 A FI 953851A FI 953851 A0 FI953851 A0 FI 953851A0
- Authority
- FI
- Finland
- Prior art keywords
- silylated
- acetylcholinesterase inhibitors
- compounds
- methods
- acetylcholinesterase
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93400385 | 1993-02-16 | ||
| EP93400385A EP0611769A1 (en) | 1993-02-16 | 1993-02-16 | Silylated acetylcholinesterase inhibitors |
| US9400720 | 1994-01-25 | ||
| PCT/US1994/000720 WO1994019356A1 (en) | 1993-02-16 | 1994-01-25 | Silylated acetylcholinesterase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI953851A0 true FI953851A0 (sv) | 1995-08-15 |
| FI953851A FI953851A (sv) | 1995-08-15 |
| FI111461B FI111461B (sv) | 2003-07-31 |
Family
ID=8214682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI953851A FI111461B (sv) | 1993-02-16 | 1995-08-15 | Förfarande för framställning av terapeutiskt användbara silylerade acetylkolinesterasinhibitorer |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP0611769A1 (sv) |
| JP (1) | JP3516955B2 (sv) |
| KR (1) | KR100336547B1 (sv) |
| CN (1) | CN1043575C (sv) |
| AT (1) | ATE152725T1 (sv) |
| AU (1) | AU672885B2 (sv) |
| CA (1) | CA2154870C (sv) |
| DE (1) | DE69403068T2 (sv) |
| DK (1) | DK0684951T3 (sv) |
| ES (1) | ES2104358T3 (sv) |
| FI (1) | FI111461B (sv) |
| GR (1) | GR3024151T3 (sv) |
| HU (1) | HUT72736A (sv) |
| IL (1) | IL108623A0 (sv) |
| MX (1) | MX9401175A (sv) |
| NO (1) | NO305517B1 (sv) |
| NZ (1) | NZ262247A (sv) |
| WO (1) | WO1994019356A1 (sv) |
| ZA (1) | ZA94925B (sv) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0627400A1 (en) * | 1993-06-04 | 1994-12-07 | Merrell Dow Pharmaceuticals Inc. | Aromatic acetylcholinesterase inhibitors |
| CN100431539C (zh) * | 2004-01-12 | 2008-11-12 | 和泓生物技术（上海）有限公司 | 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用 |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| NZ579310A (en) | 2007-03-01 | 2012-03-30 | Probiodrug Ag | Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof |
| DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
| US8486940B2 (en) | 2009-09-11 | 2013-07-16 | Probiodrug Ag | Inhibitors |
| CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
| EP2542549B1 (en) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| BR112012022478B1 (pt) | 2010-03-10 | 2021-09-21 | Probiodrug Ag | Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
| EP3827820A1 (en) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam for improving cognitive function |
| BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| CN112047973B (zh) * | 2019-06-06 | 2022-11-18 | 上海科技大学 | 一种大麻素类化合物，其制备方法、组合物和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0403713A1 (en) * | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Novel acetylcholinesterase inhibitors |
-
1993
- 1993-02-16 EP EP93400385A patent/EP0611769A1/en not_active Withdrawn
-
1994
- 1994-01-25 HU HU9502406A patent/HUT72736A/hu unknown
- 1994-01-25 ES ES94908615T patent/ES2104358T3/es not_active Expired - Lifetime
- 1994-01-25 EP EP94908615A patent/EP0684951B1/en not_active Expired - Lifetime
- 1994-01-25 DK DK94908615.1T patent/DK0684951T3/da active
- 1994-01-25 CN CN94191196A patent/CN1043575C/zh not_active Expired - Fee Related
- 1994-01-25 WO PCT/US1994/000720 patent/WO1994019356A1/en active IP Right Grant
- 1994-01-25 CA CA002154870A patent/CA2154870C/en not_active Expired - Fee Related
- 1994-01-25 DE DE69403068T patent/DE69403068T2/de not_active Expired - Lifetime
- 1994-01-25 NZ NZ262247A patent/NZ262247A/en unknown
- 1994-01-25 JP JP51897494A patent/JP3516955B2/ja not_active Expired - Fee Related
- 1994-01-25 AT AT94908615T patent/ATE152725T1/de active
- 1994-01-25 KR KR1019950703485A patent/KR100336547B1/ko not_active IP Right Cessation
- 1994-01-25 AU AU61641/94A patent/AU672885B2/en not_active Ceased
- 1994-02-10 ZA ZA94925A patent/ZA94925B/xx unknown
- 1994-02-11 IL IL10862394A patent/IL108623A0/xx unknown
- 1994-02-15 MX MX9401175A patent/MX9401175A/es not_active Application Discontinuation
-
1995
- 1995-08-15 FI FI953851A patent/FI111461B/sv not_active IP Right Cessation
- 1995-08-15 NO NO953201A patent/NO305517B1/no unknown
-
1997
- 1997-07-16 GR GR970401801T patent/GR3024151T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69403068D1 (en) | 1997-06-12 |
| KR100336547B1 (ko) | 2002-11-02 |
| ATE152725T1 (de) | 1997-05-15 |
| AU6164194A (en) | 1994-09-14 |
| EP0611769A1 (en) | 1994-08-24 |
| AU672885B2 (en) | 1996-10-17 |
| NZ262247A (en) | 1996-01-26 |
| JP3516955B2 (ja) | 2004-04-05 |
| CN1043575C (zh) | 1999-06-09 |
| DE69403068T2 (de) | 1997-12-11 |
| ES2104358T3 (es) | 1997-10-01 |
| GR3024151T3 (en) | 1997-10-31 |
| EP0684951A1 (en) | 1995-12-06 |
| MX9401175A (es) | 1994-08-31 |
| JPH08507059A (ja) | 1996-07-30 |
| WO1994019356A1 (en) | 1994-09-01 |
| DK0684951T3 (da) | 1997-05-26 |
| IL108623A0 (en) | 1994-05-30 |
| EP0684951B1 (en) | 1997-05-07 |
| CA2154870A1 (en) | 1994-09-01 |
| FI111461B (sv) | 2003-07-31 |
| NO305517B1 (no) | 1999-06-14 |
| KR960701068A (ko) | 1996-02-24 |
| HUT72736A (en) | 1996-05-28 |
| NO953201L (no) | 1995-08-15 |
| ZA94925B (en) | 1994-08-25 |
| NO953201D0 (no) | 1995-08-15 |
| FI953851A (sv) | 1995-08-15 |
| CN1117733A (zh) | 1996-02-28 |
| CA2154870C (en) | 1998-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
| ATE152725T1 (de) | Silylierte acetylcholinesterase inhibitoren | |
| DE69427869D1 (de) | Botulinumtoxine zur behandlung von hyperhydrosis | |
| MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
| ES2106965T3 (es) | Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa. | |
| HUT71550A (en) | Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis | |
| DE69405711D1 (de) | Behandlung von rueckstandsoel | |
| IN167848B (sv) | ||
| DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
| DE69432626D1 (de) | Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen | |
| NO982582L (no) | Fremgangsmaate for behandling av smerte | |
| ITMI930571A1 (it) | Procedimento ed apparecchiatura per l'analisi di composti volatili organici. | |
| ATE140228T1 (de) | Hydroxymethyl-indolizidine und -chinolizidine | |
| DE59305800D1 (de) | Werkzeug zur behandlung von oberflächen von bauteilen | |
| FI933169A (sv) | Transuretralt laserbehandlingsfoerfarande |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: AVENTIS INC. Free format text: AVENTIS INC. |
|
| PC | Transfer of assignment of patent |
Owner name: AVENTISUB II INC. Free format text: AVENTISUB II INC. |
|
| MM | Patent lapsed |